Skip to content

AVIDITY BIOSCIENCES, INC.

CIK 0001599901

← back to feed
Revenue (TTM)
$20.23M
+72.1% YoY FY Feb 2026
Net Income (TTM)
−$527.93M
−112.4% YoY FY Feb 2026
EPS Diluted (TTM)
−$4.03
−72.0% YoY FY Feb 2026
Gross Margin
—
FY Feb 2026
Operating Margin
-2,914.3%
FY Feb 2026
Net Margin
-2,609.5%
FY Feb 2026
Free Cash Flow (TTM)
−$281M
FY Feb 2026
Cash
$382.52M
FY Feb 2026
Total Debt
$0
FY Feb 2026
Shares Outstanding
155.15M sh
FY Feb 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings